Cargando…

Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis

A new drug Bedaquiline, a diarylquinoline agent has been approved by the Food and Drug Administration for the treatment of pulmonary multidrug-resistant tuberculosis. It has been given approval for use along with the basic regimen with only conditional access through the National Program for tubercu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshkar, Anuradha T, Shirure, Prashant A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516320/ https://www.ncbi.nlm.nih.gov/pubmed/36185922 http://dx.doi.org/10.7759/cureus.28519

Ejemplares similares

6-Cyano Analogues of Bedaquiline as Less Lipophilic and Potentially Safer Diarylquinolines for Tuberculosis
por: Tong, Amy S. T., et al.
Publicado: (2017)

Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
por: Almeida, Deepak, et al.
Publicado: (2021)

Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis
por: Xu, Jian, et al.
Publicado: (2021)

Factors related to previous tuberculosis treatment of patients with multidrug-resistant tuberculosis in Bangladesh
por: Rifat, Mahfuza, et al.
Publicado: (2015)

A Rare Case of Multidrug-Resistant Tuberculosis Affecting the Pleura
por: Jamal, Khalid, et al.
Publicado: (2022)

Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis
por: Mvelase, Nomonde Ritta, et al.
Publicado: (2019)

Evaluation of Rpoβ Gene and Its Various Mutants in Multidrug-Resistant Tuberculosis Cases by GeneXpert Method
por: S, Jayalakshmi, et al.
Publicado: (2022)

Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial
por: Fox, Greg J, et al.
Publicado: (2020)

National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in Ethiopia: a 10-year retrospective cohort study
por: Tola, Habteyes, et al.
Publicado: (2021)

Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis
por: Mbuagbaw, Lawrence, et al.
Publicado: (2019)

Bedaquiline for multidrug-resistant tuberculosis and QTc prolongation in California
por: Katrak, Shereen, et al.
Publicado: (2021)

Prevalence, antimicrobial susceptibility pattern and multidrug resistance of methicillin-resistant Staphylococcus aureus isolated from clinical samples at a tertiary care teaching hospital: an observational, cross-sectional study from the Himalayan country, Nepal
por: Adhikari, Prashant, et al.
Publicado: (2023)

Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
por: Davies Forsman, Lina, et al.
Publicado: (2018)

Multidrug-Resistant Staphylococcus aureus Isolates in a Tertiary Care Hospital, Kingdom of Bahrain
por: AlSaleh, Abdullah, et al.
Publicado: (2023)

Cohort Study of Pulmonary Tuberculosis (COSMOTB) identifying drug-resistant mutations: protocol for a prospective observational study in Korea
por: Min, Jinsoo, et al.
Publicado: (2018)

Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa isolated from bloodstream infections from Qatar
por: Sid Ahmed, Mazen A., et al.
Publicado: (2021)

Analysis of the challenges in implementing guidelines to prevent the spread of multidrug-resistant gram-negatives in Europe
por: Tacconelli, Evelina, et al.
Publicado: (2019)

A Case Report of Renal Tuberculosis With Associated Unusual Pulmonary Findings
por: Almazloum, Abdullah, et al.
Publicado: (2021)

Primary Extrapulmonary Rifampicin Mono-Resistant Tuberculosis of the Knee in an Indian Female Without Pulmonary Involvement: The World's First Case
por: Yadav, Sankalp
Publicado: (2023)

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
por: Gao, Jing-Tao, et al.
Publicado: (2021)

Sulbactam and Colistin Susceptibility Pattern Among Multidrug-Resistant Acinetobacter Isolates From Respiratory Samples
por: Sengupta, Mallika, et al.
Publicado: (2022)

Stool specimen for diagnosis of pulmonary tuberculosis in adults: a systematic review
por: Sultana, Saima, et al.
Publicado: (2023)

Reactivation of Pulmonary Tuberculosis During Treatment of Chronic Myelomonocytic Leukemia
por: Pescatore, Jay, et al.
Publicado: (2021)

Assessment of Lipid Profile in Patients With Pulmonary Tuberculosis: An Observational Study
por: Parivakkam Mani, Anbumaran, et al.
Publicado: (2023)

New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
por: Leibert, Eric, et al.
Publicado: (2014)

Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
por: Li, Yang, et al.
Publicado: (2018)

Treatment Outcomes of Patients with Multidrug-Resistant Tuberculosis: Concern to Bedaquiline
por: Putra, Oki Nugraha, et al.
Publicado: (2021)

Predictors of Change in the Anemia Status Among Pulmonary Tuberculosis Patients Following Anti-tuberculosis Treatment in Puducherry, India
por: Leon, Jovita, et al.
Publicado: (2023)

Quality of Life Amongst Multidrug-Resistant TB Patients: An Exploratory Study About Distributive Dimensions and Interactions
por: Sharma, Shweta, et al.
Publicado: (2022)

Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults
por: Peetluk, Lauren S., et al.
Publicado: (2021)

Stenotophomonas Maltophilia As Not Just a Mere Colonozer: Two Cases of Urinary Tract Infection and Multidrug-Resistant Respiratory Infection
por: Umar, Zaryab, et al.
Publicado: (2022)

Early and Appropriate Use of Ceftazidime-Avibactam in the Management of Multidrug-Resistant Gram-Negative Bacterial Infections in the Indian Scenario
por: Swaminathan, Subramanian, et al.
Publicado: (2022)

When Multidrug-Resistant Organism (MDRO)-Positive ICU Patient Isolation and Cohorting Is Not Feasible, What Comes Next?
por: Iordanou, Stelios, et al.
Publicado: (2021)

Diagnostic yield of post-bronchoscopy sputum for diagnosing pauci-bacillary pulmonary tuberculosis
por: Park, Joung Ha, et al.
Publicado: (2021)

Prevalence of covid-19 among patients with chronic obstructive pulmonary disease and tuberculosis
por: Muneeb Hassan, Muhammad, et al.
Publicado: (2023)

Systematic literature review of the burden and outcomes of infections due to multidrug-resistant organisms in Europe: the ABOUT-MDRO project protocol
por: Anaya-Baz, Blanca, et al.
Publicado: (2020)

Evidence-Based Interventions to Reduce the Incidence of Common Multidrug-Resistant Gram-Negative Bacteria in an Adult Intensive Care Unit
por: Althaqafi, Abdulhakeem, et al.
Publicado: (2023)

Delayed diagnosis and treatment of pulmonary tuberculosis in high-burden countries: a systematic review protocol
por: Teo, Alvin Kuo Jing, et al.
Publicado: (2019)

Stool specimen for diagnosis of pulmonary tuberculosis in adults: protocol for a systematic review and meta-analysis
por: Sultana, Saima, et al.
Publicado: (2021)

Isolated Tuberculosis of the First Metatarsal of the Right Foot Without Pulmonary Involvement: A Rare Case
por: Yadav, Sankalp, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jqmsusrcm3gc8kfkd3rs70immf